{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:33:19Z","timestamp":1779114799429,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.burns.2017.09.015","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T07:46:08Z","timestamp":1507880768000},"page":"603-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Improving mortality outcomes of Stevens Johnson syndrome\/toxic epidermal necrolysis: A regional burns centre experience"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-8606","authenticated-orcid":false,"given":"M.","family":"Nizamoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Frew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gerrish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Shelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Philp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"El-Muttardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dziewulski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.burns.2017.09.015_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"A 10-year experience with toxic epidermal necrolysis","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care Res"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004630-199601000-00008","article-title":"Experience with toxic epidermal necrolysis treated in a burn center","volume":"17","author":"Yarbrough","year":"1996","journal-title":"J Burn Care Res"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0020","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809020-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center","volume":"102","author":"McGee","year":"1998","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.burns.2016.07.026","article-title":"Steven Johnson syndrome and toxic epidermal necrolysis in a burn unit: a 15-year experience","volume":"43","author":"McCullough","year":"2017","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.burns.2006.08.014","article-title":"Toxic epidermal necrolysis (TEN) and Stevens\u2013Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach: a retrospective analysis","volume":"33","author":"Stella","year":"2007","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","article-title":"SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center","volume":"29","author":"Cartotto","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2017.09.015_bib0040","series-title":"Intravenous immunoglobulin use in the treatment of toxic epidermal necrolysis and stevens-johnson syndrome: a 10-year retrospective analysis of patients of a single burn center","author":"Cooper","year":"2014"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0305-4179(00)00136-4","article-title":"Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong","volume":"27","author":"Ying","year":"2001","journal-title":"Burns"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0050","first-page":"185","article-title":"Treatment of toxic epidermal necrolysis with moisture-retentive ointment: a case report and review of the literature","volume":"29","author":"Atiyeh","year":"2003","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.burns.2007.06.008","article-title":"Toxic epidermal necrolysis: use of Biobrane\u00ae for skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients","volume":"34","author":"Boorboor","year":"2008","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000070957","article-title":"Effect of high-dose intravenous immunoglobulin therapy in Stevens\u2013Johnson syndrome: a retrospective, multicenter study","volume":"207","author":"Prins","year":"2003","journal-title":"Dermatology"},{"issue":"15","key":"10.1016\/j.burns.2017.09.015_bib0065","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2165\/00003495-200565150-00002","article-title":"Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IVIg)","volume":"65","author":"Faye","year":"2005","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0070","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1542\/peds.112.6.1430","article-title":"Use of intravenous immunoglobulin in children with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature","volume":"112","author":"Metry","year":"2003","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.burns.2017.09.015_bib0075","first-page":"2494","article-title":"Intravenous immunoglobulin therapy for children with Stevens\u2013Johnson syndrome","volume":"27","author":"Morici","year":"2000","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.BCR.0000105096.93526.27","article-title":"Toxic epidermal necrolysis: does immunoglobulin make a difference?","volume":"25","author":"Brown","year":"2004","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0090","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.burns.2017.09.015_bib0095","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.burns.2008.12.011","article-title":"Accurate debridement of toxic epidermal necrolysis using Versajet\u00ae","volume":"36","author":"Dillon","year":"2010","journal-title":"Burns"},{"issue":"8","key":"10.1016\/j.burns.2017.09.015_bib0105","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.burns.2017.09.015_bib0110","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"},{"issue":"8","key":"10.1016\/j.burns.2017.09.015_bib0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1445-2197.2007.04184.x","article-title":"Toxic epidermal necrolysis\/Stevens\u2013Johnson syndrome: current trends in management","volume":"77","author":"Dalli","year":"2007","journal-title":"ANZ J Surg"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in US burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Res"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.burns.2017.09.015_bib0130","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.2147\/DDDT.S71736","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People\u2019s Republic of China","volume":"8","author":"Sun","year":"2014","journal-title":"Drug Des Dev Ther"},{"issue":"24","key":"10.1016\/j.burns.2017.09.015_bib0135","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.burns.2006.01.023","article-title":"Dermal preservation using the Versajet\u00ae hydrosurgery system for debridement of paediatric burns","volume":"32","author":"Cubison","year":"2006","journal-title":"Burns"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.bcr.0000185398.13095.c5","article-title":"The Versajet\u2122 water dissector: a new tool for tangential excision","volume":"26","author":"Klein","year":"2005","journal-title":"J Burn Care Res"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.burns.2005.07.010","article-title":"Debridement of burn wounds with a water jet surgical tool","volume":"32","author":"Rennekampff","year":"2006","journal-title":"Burns"},{"issue":"3","key":"10.1016\/j.burns.2017.09.015_bib0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.burns.2006.08.043","article-title":"Versajet\u00ae hydrosurgery in burn wound debridement: a preliminary experience","volume":"33","author":"Gravante","year":"2007","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0160","first-page":"64","article-title":"Comparison of wound irrigation and tangential hydrodissection in bacterial clearance of contaminated wounds: results of a randomized, controlled clinical study","volume":"53","author":"Granick","year":"2007","journal-title":"Ostomy Wound Manage"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0165","first-page":"A88","article-title":"The impact of hydrosurgical debridement on wounds containing bacterial biofilms","volume":"18","author":"Allan","year":"2010","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.burns.2017.09.015_bib0170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archderm.140.2.160","article-title":"A semisynthetic bilaminar skin substitute used to treat pediatric full-body toxic epidermal necrolysis","volume":"140","author":"Bannasch","year":"2004","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000637-199508000-00002","article-title":"Toxic epidermal necrolysis: a review and report of the successful use of Biobrane for early wound coverage","volume":"35","author":"Bradley","year":"1995","journal-title":"Ann Plast Surg"},{"issue":"5","key":"10.1016\/j.burns.2017.09.015_bib0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00004630-199909000-00013","article-title":"Skin coverage with biobrane biomaterial for the treatment of patients with toxic epidermal necrolysis","volume":"20","author":"Ar\u00e9valo","year":"1999","journal-title":"J Burn Care Res"},{"issue":"5","key":"10.1016\/j.burns.2017.09.015_bib0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0305-4179(88)90013-7","article-title":"A comparison of biobrane vs. homograft for coverage of contaminated burn wounds","volume":"14","author":"Gonce","year":"1988","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.BCR.0000170119.87879.CA","article-title":"A prospective, randomized trial of acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?","volume":"26","author":"Varas","year":"2005","journal-title":"J Burn Care Res"},{"issue":"3","key":"10.1016\/j.burns.2017.09.015_bib0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004630-199905000-00006","article-title":"Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing","volume":"20","author":"Yin","year":"1999","journal-title":"J Burn Care Res"},{"issue":"5","key":"10.1016\/j.burns.2017.09.015_bib0200","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J Investig Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000018112","article-title":"Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis?","volume":"198","author":"Paquet","year":"1999","journal-title":"Dermatology"},{"issue":"44","key":"10.1016\/j.burns.2017.09.015_bib0210","first-page":"1656","article-title":"Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease: potential for therapeutic inhibition","volume":"130","author":"French","year":"2000","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"5388","key":"10.1016\/j.burns.2017.09.015_bib0215","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0220","first-page":"10","article-title":"Toxic epidermal necrolysis: current concepts in pathogenesis and treatment","volume":"66","author":"Saha","year":"2000","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0225","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.bjps.2016.01.034","article-title":"UK guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"69","author":"Creamer","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"8","key":"10.1016\/j.burns.2017.09.015_bib0230","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bjps.2014.04.003","article-title":"Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm","volume":"67","author":"Abela","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0235","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/PRS.0b013e3181773d5d","article-title":"Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach","volume":"122","author":"Dorafshar","year":"2008","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4103\/0378-6323.191134","article-title":"Guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: an Indian perspective","volume":"82","author":"Gupta","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0245","first-page":"42","article-title":"Toxic epidermal necrolysis-management issues and treatment options","volume":"1","author":"Widgerow","year":"2011","journal-title":"Int J Burns Trauma"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0250","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta\u2010analysis","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.burns.2017.09.015_bib0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098611404094","article-title":"Systematic review of treatments for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality","volume":"2","author":"Roujeau","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/ijd.12423","article-title":"Intravenous immunoglobulin in the treatment of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a meta\u2010analysis with meta\u2010regression of observational studies","volume":"54","author":"Barron","year":"2015","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.burns.2017.09.015_bib0265","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00004630-199709000-00008","article-title":"Toxic epidermal necrolysis","volume":"18","author":"Murphy","year":"1997","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2017.09.015_bib0270","doi-asserted-by":"crossref","DOI":"10.2500\/108854100778250914","article-title":"Corticosteroid therapy in an additional 13 cases of Stevens\u2013Johnson syndrome: a total series of 67 cases","author":"Tripathi","year":"2000","journal-title":"Allergy and Asthma Proceedings"},{"issue":"3","key":"10.1016\/j.burns.2017.09.015_bib0275","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.PRS.0000019761.69444.10","article-title":"Outcome of patients with toxic epidermal necrolysis syndrome revisited","volume":"110","author":"Ducic","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0280","doi-asserted-by":"crossref","DOI":"10.1080\/00015550510038232","article-title":"Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients","volume":"85","author":"Kim","year":"2005","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-0214","article-title":"Dexamethasone pulse therapy for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"87","author":"Kardaun","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.burns.2017.09.015_bib0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00128071-200809010-00003","article-title":"Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Kim","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.burns.2017.09.015_bib0295","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1365-4632.2009.04166.x","article-title":"Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: a retrospective comparative study in China","volume":"48","author":"Yang","year":"2009","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0300","first-page":"743","article-title":"High-dose intravenous immunoglobulins in the treatment of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases","volume":"20","author":"Chen","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.burns.2017.09.015_bib0305","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jaad.2013.04.007","article-title":"Methylprednisolone pulse therapy for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers","volume":"69","author":"Hirahara","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.burns.2017.09.015_bib0310","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Ar\u00e9valo","year":"2000","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"10.1016\/j.burns.2017.09.015_bib0315","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","article-title":"Open trial of ciclosporin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"163","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.burns.2017.09.015_bib0320","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4103\/0378-6323.116738","article-title":"Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid","volume":"79","author":"Singh","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"10.1016\/j.burns.2017.09.015_bib0325","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","article-title":"Retrospective review of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine","volume":"71","author":"Kirchhof","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.burns.2017.09.015_bib0330","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"UK guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2017.09.015_bib0335","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Fouchard","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.burns.2017.09.015_bib0340","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archderm.140.7.890","article-title":"Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States","volume":"140","author":"Trent","year":"2004","journal-title":"Arch Dermatol"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417917305041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417917305041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T03:35:25Z","timestamp":1693107325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417917305041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0305417917305041"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2017.09.015","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving mortality outcomes of Stevens Johnson syndrome\/toxic epidermal necrolysis: A regional burns centre experience","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2017.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}